arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

MUSTANG BIO, INC.

MBIO
$0.54 ▲ +0.03 (+5.15%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
44 Visible periods
21 Metrics
Peer-ranked Benchmarks
Price Chart
46
Health
Weak
Neutral
auto_awesome

Analytical Summary

MUSTANG BIO, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $3.6M
Dividend Yield
Revenue Growth
Op. Margin
ROIC -12.3%
FCF / Share $-0.14
Trailing P/E
Price / Book 0.5x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 21, 2026.

44-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-1.07M
↓ -40.7%
FCF / Share Free cash flow per share
$-0.14
↑ +4.1%

Health Breakdown

Returns
28
Cash Quality
91

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 11 years · 44 quarters